Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled phase 2 trial of V0251 (acetyl-L-leucine) in vestibular neuritis
2007-005054-23Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levacetylleucine in vestibular neuritis and vertigo (4 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Peak slow phase eye velocity of horizontal spontaneous nystagmus on Day 4. Started Oct 2007; status: completed.
02
Drugs
levacetylleucine
03
Conditions
vestibular neuritisvertigo
Beyond the preview
Go deeper on 2007-005054-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005054-23.